世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

体外診断の市場規模および予測(2020年~2030年)、世界および地域シェア、動向、成長機会分析 レポートの対象範囲製品・サービス別(試薬・キット、機器、ソフトウェア・サービス)、技術別(免疫測定/免疫化学、臨床化学、分子診断、微生物学、血糖自己測定、凝固・止血、血液学、尿検査、その他)、用途(感染症、糖尿病、腫瘍、心臓病、自己免疫疾患、腎臓病、その他)、エンドユーザー(病院、研究所、在宅医療、その他)、地域(北米、欧州、アジア太平洋、中東・アフリカ、中南米)


In-Vitro Diagnostic Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), End User (Hospitals, Laboratories, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)

体外診断薬市場は、2022年の723億9,380万米ドルから2030年には112億3,351万米ドルに成長すると予測されており、2022年から2030年までの年平均成長率は5.6%と予測されている。慢性疾患の増加、技術の進歩、老年人... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2023年9月18日 US$4,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
210 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

体外診断薬市場は、2022年の723億9,380万米ドルから2030年には112億3,351万米ドルに成長すると予測されており、2022年から2030年までの年平均成長率は5.6%と予測されている。慢性疾患の増加、技術の進歩、老年人口の増加が、体外診断薬市場の成長を促進する注目すべき要因である。

体外診断(IVD)とは、人体から採取した血液や組織などのサンプルを用いて行う検査のことである。体外診断薬は病気やその他の状態を検出することに特化しており、病気の治療、処置、予防に役立てるため、人の全体的な健康状態をモニターするために使用される。さらに、体外診断薬は、特定の治療や療法の恩恵を受けそうな患者を特定する精密医療にも利用されることがある。そのため、これらの体外診断には、ゲノム変異を検出するために人のDNAをスキャンする次世代シークエンシング検査が含まれる。

慢性疾患と感染症の有病率の増加

世界では感染症の流行が急激に増加している。これらの病気は、ウイルス、細菌、寄生虫などの病原性微生物が主な原因である。劣悪な衛生環境、公衆衛生の欠如、大気汚染レベルの上昇、安全な飲料水の不足といった要因が、感染症の蔓延に大きな役割を果たしている。カナダ公衆衛生局によると、カナダでは2020年に合計6,736人のC型肝炎患者(急性、慢性、特定不能の合計)が報告された。

慢性疾患には、がん、慢性呼吸器疾患、糖尿病、心臓病が多く含まれる。アルコールやタバコの消費量の増加、不健康な食生活の採用、運動不足、肥満の蔓延といった生物学的危険因子のために、これらの疾患の罹患率は世界的に急増している。慢性疾患は世界的な死亡原因の第1位である。米国疾病予防管理センター(CDC)によると、アメリカ人の10人に6人は、脳卒中、がん、心臓病、糖尿病など、少なくとも1つの慢性疾患を抱えて生活している。これらの慢性疾患は、米国における死亡や身体障害の主な原因であり、医療費も急増している。2021年の米国の医療費は4兆1,000億ドルだった。また、CDCのデータによると、心臓病は男性、女性、ほとんどの人種・民族の死亡原因の第1位となっている。

CDCのデータによると、冠動脈疾患(CAD)は成人の死亡原因として最も一般的である。2021年には約375,476人がCADが原因で死亡した。世界保健機関(WHO)の2022年全国糖尿病統計報告書に発表された推計によると、世界で4億2200万人が糖尿病を患っており、その大多数が低・中所得国に住んでいる。さらに、毎年150万人が糖尿病に直接関連して死亡している。過体重、遺伝的条件、加齢、座りっぱなしのライフスタイルなどが糖尿病の有病率を押し上げている。Cancer Research UKの報告書に掲載された推計によると、2020年に世界で新たに報告されたがん患者は1,810万人で、2040年には2,800万人に増加すると予想されている。したがって、心血管疾患、癌、糖尿病、呼吸器疾患などの感染症や慢性疾患の有病率の上昇が、体外診断薬市場の成長を牽引している。

市場動向

個別化医療とゲノミクスへの需要の高まり

北米は個別化医療とゲノミクス研究の最前線である。ゲノミクスと分子診断学の日常診療への統合が進んでいる。先進的な遺伝学の開発に携わる企業は、体外診断薬市場に大きなビジネスチャンスをもたらしている。北米、特に米国とカナダは、疾患の遺伝的基盤に関する理解と知識、バイオマーカーの同定、標的療法の開発に顕著に貢献するゲノム研究センターの拠点となっている。これら両国は、ゲノミクスを臨床診療に統合する精密医療イニシアチブを立ち上げている。北米はがんゲノミクスのリーダーであり、さまざまな種類のがんに関連する遺伝的要因の解明に焦点を当てた広範な研究や臨床試験が行われている。これらの臨床試験は、患者の腫瘍の遺伝的特徴に基づいて、標的療法、免疫療法、その他の革新的な治療法の有効性を評価することを目的としている。米国癌学会は、2023年に米国で新たに190万人の癌患者(1日当たり5,370人)が発生し、609,820人が癌で死亡すると推定している。このような高い罹患率に伴い、これらの患者の生活の質を向上させる効果的な治療が急務となっている。

個別化医療では、体外診断検査を患者に実施し、患者固有の特徴に基づいてサブグループに層別化する。個別化医療の分野は、ゲノム配列決定、分子プロファイリング、その他の診断技術の進歩とともに、標的を絞った正確で個別化された治療アプローチを提供することにより、医療に革命をもたらす可能性を秘めている。遺伝学は世界的にますます身近なものとなっている。2022年11月、ロシュ、Cancer Research UK、マンチェスター大学は、多剤併用精密医療DETERMINE試験の開始を発表した。この試験は、より一般的ながん種に対して認可されている薬剤を含め、利用可能な薬剤が希少がん種の患者に有益かどうかを評価することを目的としている。この試験では、希少がん種の成人および小児患者を募集した。23andMe社やAncestryDNA社などの企業は、直接消費者に遺伝子検査キットを提供し、個人が自分の先祖や遺伝的特徴、潜在的な健康リスクについて洞察を得ることを可能にしている。医療提供者もまた、治療方針を決定するための遺伝子検査を提供している。このように、個別化医療とゲノミクスの需要は、予測期間中の体外診断薬市場の成長を促進するだろう。

体外診断の世界市場」は、製品・サービス、用途、技術、エンドユーザー、地域によって区分される。製品・サービスに基づき、市場は試薬・キット、機器、ソフトウェア・サービスに区分される。2022年には、試薬とキットのセグメントが市場で最大のシェアを占めている。試薬・キット市場の成長が予測される背景には、自己検査キットやPOCデバイスの絶大な人気、作業を簡素化し正確な結果を提供する自動化機器の入手可能性と導入の増加がある。ウイルスや真菌による感染症が増加し、衛生状態が不十分なため、試薬の使用が促進されている。このため、体外診断薬市場のプレーヤーは、より良い患者管理とケアのために、優れた品質の分子試薬とキットを提供している。

欧州医薬品庁、緊急使用認可、疾病管理予防センター、国際糖尿病連合、体外診断研究などは体外診断薬市場調査報告書作成時に参照した関連情報源の一部である。

ページTOPに戻る


目次

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Vitro Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. In-Vitro Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraint
5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
5.3 Market Opportunities
5.3.1 Integration of IVD with Digital Health Technologies
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicine and Genomics
6. In-Vitro Diagnostics Market - Global Market Analysis
6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
7.1 Overview
7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Instruments
7.5.1 Overview
7.5.2 Instruments: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Immunoassay/ Immunochemistry
8.3.1 Overview
8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Chemistry
8.4.1 Overview
8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Molecular Diagnostics
8.5.1 Overview
8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Microbiology
8.6.1 Overview
8.6.2 Microbiology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Blood Glucose Self-Monitoring
8.7.1 Overview
8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Coagulation and Hemostasis
8.8.1 Overview
8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Hematology
8.9.1 Overview
8.9.2 Hematology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Urinalysis
8.10.1 Overview
8.10.2 Urinalysis: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Diseases: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Cardiology
9.6.1 Overview
9.6.2 Cardiology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Autoimmune Diseases
9.7.1 Overview
9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Nephrology
9.8.1 Overview
9.8.2 Nephrology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Laboratories
10.4.1 Overview
10.4.2 Laboratories: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Homecare
10.5.1 Overview
10.5.2 Homecare: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 North America: In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: In-Vitro Diagnostics Market, by Country
11.1.7.1 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: In-Vitro Diagnostics Market
11.2.1 Overview
11.2.2 Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: In-Vitro Diagnostics Market, by Country
11.2.7.1 Germany: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 France: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 UK: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: In-Vitro Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
11.3.7.1 China: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: In-Vitro Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
11.4.7.1 South Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: In-Vitro Diagnostics Market
11.5.1 Overview
11.5.2 South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
11.5.7.1 Brazil: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in North America In-Vitro Diagnostics Market
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Siemens AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Becton Dickinson and Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Qiagen NV
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

 

ページTOPに戻る


 

Summary

The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.

In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.

Increasing Prevalence of Chronic and Infectious Diseases

The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.

Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country’s healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.

According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.

Market Trend

Increasing Demand for Personalized Medicine and Genomics

North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients’ tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.

Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.

The “Global In-Vitro Diagnostic Market” is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.

European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Vitro Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. In-Vitro Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraint
5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
5.3 Market Opportunities
5.3.1 Integration of IVD with Digital Health Technologies
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicine and Genomics
6. In-Vitro Diagnostics Market - Global Market Analysis
6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
7.1 Overview
7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Instruments
7.5.1 Overview
7.5.2 Instruments: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Immunoassay/ Immunochemistry
8.3.1 Overview
8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Chemistry
8.4.1 Overview
8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Molecular Diagnostics
8.5.1 Overview
8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Microbiology
8.6.1 Overview
8.6.2 Microbiology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Blood Glucose Self-Monitoring
8.7.1 Overview
8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Coagulation and Hemostasis
8.8.1 Overview
8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Hematology
8.9.1 Overview
8.9.2 Hematology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Urinalysis
8.10.1 Overview
8.10.2 Urinalysis: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Diseases: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Cardiology
9.6.1 Overview
9.6.2 Cardiology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Autoimmune Diseases
9.7.1 Overview
9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Nephrology
9.8.1 Overview
9.8.2 Nephrology: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Global In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Laboratories
10.4.1 Overview
10.4.2 Laboratories: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Homecare
10.5.1 Overview
10.5.2 Homecare: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 North America: In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: In-Vitro Diagnostics Market, by Country
11.1.7.1 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: In-Vitro Diagnostics Market
11.2.1 Overview
11.2.2 Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: In-Vitro Diagnostics Market, by Country
11.2.7.1 Germany: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 France: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 UK: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: In-Vitro Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
11.3.7.1 China: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: In-Vitro Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
11.4.7.1 South Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: In-Vitro Diagnostics Market
11.5.1 Overview
11.5.2 South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
11.5.7.1 Brazil: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in North America In-Vitro Diagnostics Market
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Siemens AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Becton Dickinson and Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Qiagen NV
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(diagnostic)の最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る